vaccines

research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Merck is licensing one of Evaxion’s AI platform-based vaccine candidates, offering the biotech up to $592 million for rights to the preclinical asset.

Gabrielle Masson Sep 25, 2025 7:00am

HHS headquarters as seen on April 02 2025

Fierce Pharma

RFK Jr.'s ACIP delivers perplexing vote on MMRV vaccine guidance

Sep 18, 2025 6:33pm

Robert F Kennedy Jr conducts a news conference to discuss the Centers for Disease Control and Preventions latest Autism a

Fierce Pharma

RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation

Sep 4, 2025 3:51pm

Pfizer, Valneva boosted by updated Lyme vaccine data

Sep 3, 2025 10:19am

After 'complete standstill,' biotech market reaches new normal

Aug 20, 2025 11:04am

CSL to lose up to 15% of staff, cut R&D costs, spin out vaccines

Aug 19, 2025 7:06am